Predictive Oncology Inc. — Director's Dealing 2016

Jan 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-01-06

Reporting Person: MYERS ROBERT L (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-06	Common Stock	M	15685	$2.63	Acquired	15819	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-06	Stock Options (right to buy)	$2.63	M	15685	Disposed	2025-10-20	Common Stock (15685)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	84	Indirect